Coxsackievirus A6 Infection Causes Neurogenic Pathogenesis in a Neonatal Murine Model

Coxsackievirus A6 (CVA6), a member of species A enterovirus, is associated with outbreaks of hand-foot-and-mouth disease and causes a large nationwide burden of disease. However, the molecular pathogenesis of CVA6 remains unclear. In the present study, we established a suckling Institute of Cancer Research (ICR) mouse infection model to explore the neural pathogenicity of CVA6. Five-day-old mice infected with CVA6 strain F219 showed lethargy and paralysis, and died 5 or 6 days after infection via IM injection. Cerebral edema and neuronal cell swelling were observed in the infected brain tissue, and we found that the CVA6 VP1 antigen could co-localize with GFAP-positive astrocytes in infected mouse brain using an immunofluorescence assay. CVA6 strain F219 can also infect human glioma (U251) cells. Transcriptome analysis of brain tissues from infected mice and infected U251 cells showed that significantly differentially expressed genes were enriched in antiviral and immune response and neurological system processes. These results indicate that CVA6 could cause neural pathogenesis and provide basic data for exploring the mechanism of how host–cell interactions affect viral replication and pathogenesis. Importance: Coxsackievirus A6 (CVA6) surpasses the two main pathogens, enterovirus 71 (EV-A71) and coxsackievirus A16 (CVA16), which are the leading pathogens causing HFMD in many provinces of China. In our study, CVA6 infection caused neurogenic pathogenesis in a neonatal murine model, manifesting as cerebral edema and neuronal cell swelling, CVA6 VP1 antigen could co-localize with GFAP-positive astrocytes in the infected mouse brain. Based on CVA6-infected brain tissue and U251 cell transcriptome analysis, we found upregulated antiviral and immune response-related genes such as Zbp1, Usp18, Oas2, Irf7, Ddx60, Ifit3, Ddx58, and Isg15, while the neurological system process-related genes were downregulated, including Fcrls, Ebnrb, Cdk1, and Anxa5.

[1]  N. Roberts,et al.  Clinical manifestations of coxsackievirus A6: what a dermatologist needs to know , 2022, International journal of dermatology.

[2]  Bo Zhang,et al.  Transcriptome sequencing analysis of echovirus 30 infection reveals its potential pathogenesis , 2022, Frontiers in Microbiology.

[3]  G. Duan,et al.  A mouse-adapted CVA6 strain exhibits neurotropism and triggers systemic manifestations in a novel murine model , 2022, Emerging microbes & infections.

[4]  Wenbo Xu,et al.  Pathological Characteristics of Echovirus 30 Infection in a Mouse Model , 2022, Journal of virology.

[5]  J. Juang,et al.  Neurotropic EV71 causes encephalitis by engaging intracellular TLR9 to elicit neurotoxic IL12-p40-iNOS signaling , 2022, Cell Death & Disease.

[6]  Wenbo Xu,et al.  Pathological Features of Echovirus-11-Associated Brain Damage in Mice Based on RNA-Seq Analysis , 2021, Viruses.

[7]  Huiqing Liu,et al.  USP18 positively regulates innate antiviral immunity by promoting K63-linked polyubiquitination of MAVS , 2021, Nature Communications.

[8]  Xiaomei Lu,et al.  A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs , 2021, Frontiers in Immunology.

[9]  M. Kaul,et al.  Innate Immune Sensing of Viruses and Its Consequences for the Central Nervous System , 2021, Viruses.

[10]  S. Shen,et al.  Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model , 2021, Emerging microbes & infections.

[11]  Yunhui Zhang,et al.  Comprehensive analysis of differential expression profiles via transcriptome sequencing in SH-SY5Y cells infected with CV-A16 , 2020, PloS one.

[12]  M. Aepfelbacher,et al.  Neuropathology of patients with COVID-19 in Germany: a post-mortem case series , 2020, The Lancet Neurology.

[13]  Sheng Wei,et al.  Risk factors for severe hand, foot, and mouth disease infected with Coxsackievirus A6: A hospital‐based case‐control study , 2020, Journal of medical virology.

[14]  Wenbo Xu,et al.  Genetic recombination in fast-spreading coxsackievirus A6 variants: a potential role in evolution and pathogenicity , 2020, Virus Evolution.

[15]  Jie Dong,et al.  Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients , 2020, Cell Host & Microbe.

[16]  Yunhui Zhang,et al.  Transcriptome sequencing analysis of SH-SY5Y cells infected with EV71 reveals the potential neuropathic mechanisms. , 2020, Virus research.

[17]  Lisu Huang,et al.  Neonatal hand, foot, and mouth disease due to coxsackievirus A6 in Shanghai , 2019, BMC Pediatrics.

[18]  Q. Lu,et al.  A review and meta‐analysis of the epidemiology and clinical presentation of coxsackievirus A6 causing hand‐foot‐mouth disease in China and global implications , 2019, Reviews in medical virology.

[19]  Jianguo Wu,et al.  EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production , 2019, PLoS pathogens.

[20]  Zhen Zhu,et al.  Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017 , 2019, Biosafety and Health.

[21]  Yi Tan,et al.  Six amino acids of VP1 switch along with pandemic of CV-A6-associated HFMD in Guangxi, southern China, 2010-2017. , 2019, The Journal of infection.

[22]  J. Locasale,et al.  The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons , 2019, Immunity.

[23]  M. Luo,et al.  Clinical features and phylogenetic analysis of severe hand-foot-and-mouth disease caused by Coxsackievirus A6. , 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[24]  G. Ebel,et al.  An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections , 2018, Cell Reports.

[25]  Wenyan Zhang,et al.  Divergent Pathogenic Properties of Circulating Coxsackievirus A6 Associated with Emerging Hand, Foot, and Mouth Disease , 2018, Journal of Virology.

[26]  G. Neale,et al.  IRF1 Is a Transcriptional Regulator of ZBP1 Promoting NLRP3 Inflammasome Activation and Cell Death during Influenza Virus Infection , 2018, The Journal of Immunology.

[27]  Elliot J. Lefkowitz,et al.  Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV) , 2017, Nucleic Acids Res..

[28]  Juan Li,et al.  A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy , 2017, Journal of Virology.

[29]  Ting Zhao,et al.  The Preferential Infection of Astrocytes by Enterovirus 71 Plays a Key Role in the Viral Neurogenic Pathogenesis , 2016, Frontiers in cellular and infection microbiology.

[30]  C. Farina,et al.  Astrocytes: Key Regulators of Neuroinflammation. , 2016, Trends in immunology.

[31]  Kevin W. Kelley,et al.  Astrocyte-encoded positional cues maintain sensorimotor circuit integrity , 2014, Nature.

[32]  Hongling Zhao,et al.  Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection. , 2011, Virology.

[33]  N. Nagata,et al.  Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. , 2004, The Journal of general virology.

[34]  Hour‐Young Chen,et al.  Early and rapid detection of enterovirus 71 infection by an IgM-capture ELISA. , 2004, Journal of virological methods.

[35]  N. Nagata,et al.  Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71 , 2002, Journal of medical virology.